Dottikon ES Holding AG

  • Market Cap: N/A
  • Industry: Specialty Chemicals
  • ISIN: CH0582581713
CHF
331.50
-3.5 (-1.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Dottikon ES Holding AG stock-summary
stock-summary
Dottikon ES Holding AG
Specialty Chemicals
Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.
Company Coordinates stock-summary
Company Details
Hembrunnstrasse 17 , DOTTIKON None : 5605
stock-summary
Tel: 41 56 616811141 56 6168201
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Markus Blocher
Executive Chairman of the Board, Chief Executive Officer, Managing Director
Dr. Thomas Frueh
Non-Executive Deputy Chairman of the Board
Dr. Alfred Scheidegger
Non-Executive Member of the Board of Directors
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

CHF 4,977 Million ()

stock-summary
P/E

42.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

11.63%

stock-summary
Price to Book

4.79